140 related articles for article (PubMed ID: 11781653)
1. A novel type of metastatically spreading subcutaneous aspergillosis without epidermal lesions following allogeneic stem cell transplantation.
Cornely OA; Pels H; Bethe U; Seibold M; Toepelt K; Soehngen D; Ritzkowsky A
Bone Marrow Transplant; 2001 Nov; 28(9):899-901. PubMed ID: 11781653
[TBL] [Abstract][Full Text] [Related]
2. The combination of thalidomide, cyclophosphamide and dexamethasone is potentially useful in highly resistant Hodgkin's lymphoma.
García-Sanz R; González-López TJ; Vázquez L; Hermida G; Graciani IF; San Miguel JF
Eur J Haematol; 2010 Mar; 84(3):266-70. PubMed ID: 19912314
[TBL] [Abstract][Full Text] [Related]
3. [Treatment strategy of Hodgkin lymphoma].
Nagai H
Rinsho Ketsueki; 2014 Oct; 55(10):1941-51. PubMed ID: 25297759
[No Abstract] [Full Text] [Related]
4. Bendamustine salvage for the treatment of relapsed Hodgkin's lymphoma after allogeneic bone marrow transplantation.
Mian M; Farsad M; Pescosta N; Casini M; Cavattoni IM; Deola S; Cortelazzo S
Ann Hematol; 2013 Jan; 92(1):121-3. PubMed ID: 22820997
[No Abstract] [Full Text] [Related]
5. [Foliculitis in a patient with Hodkins disease].
Garau M; Relaño MT; Molina L; del Palacio A
Enferm Infecc Microbiol Clin; 2003 Feb; 21(2):101-2. PubMed ID: 12586034
[No Abstract] [Full Text] [Related]
6. Treatment outcome in children and adolescents with relapsed Hodgkin lymphoma--results of the UK HD3 relapse treatment strategy.
Shankar A; Hayward J; Kirkwood A; McCarthy K; Hewitt M; Morland B; Daw S
Br J Haematol; 2014 May; 165(4):534-44. PubMed ID: 24754633
[TBL] [Abstract][Full Text] [Related]
7. Standard therapy of advanced Hodgkin lymphoma.
Kuruvilla J
Hematology Am Soc Hematol Educ Program; 2009; ():497-506. PubMed ID: 20008235
[TBL] [Abstract][Full Text] [Related]
8. Autologous progenitor cell transplantation: prior exposure to stem cell-toxic drugs determines yield and engraftment of peripheral blood progenitor cell but not of bone marrow grafts.
Dreger P; Klöss M; Petersen B; Haferlach T; Löffler H; Loeffler M; Schmitz N
Blood; 1995 Nov; 86(10):3970-8. PubMed ID: 7579368
[TBL] [Abstract][Full Text] [Related]
9. [High-dose chemotherapy and autologous stem cell transplantation for refractory and relapsing Hodgkin's disease as first-line therapy-- studies at Sheba Medical Center--Tel Hashomer].
Avigdor A; Hardan I; Shpilberg O; Raanani P; Grotto I; Ben-Bassat I
Harefuah; 2000 Sep; 139(5-6):174-9, 248, 247. PubMed ID: 11062945
[TBL] [Abstract][Full Text] [Related]
10. Rapid regression of chemotherapy refractory lymphocyte predominant Hodgkin's disease after administration of rituximab (anti CD 20 mono- clonal antibody) and interleukin-2.
Keilholz U; Szelényi H; Siehl J; Foss HD; Knauf W; Thiel E
Leuk Lymphoma; 1999 Nov; 35(5-6):641-2. PubMed ID: 10609806
[No Abstract] [Full Text] [Related]
11. High-dose cyclophosphamide, carmustine (BCNU), and etoposide (VP16-213) with or without cisplatin (CBV +/- P) and autologous transplantation for patients with Hodgkin's disease who fail to enter a complete remission after combination chemotherapy.
Reece DE; Barnett MJ; Shepherd JD; Hogge DE; Klasa RJ; Nantel SH; Sutherland HJ; Klingemann HG; Fairey RN; Voss NJ
Blood; 1995 Jul; 86(2):451-6. PubMed ID: 7541661
[TBL] [Abstract][Full Text] [Related]
12. Thoracic positron emission tomography using 18F-fluorodeoxyglucose for the evaluation of residual mediastinal Hodgkin disease.
Weihrauch MR; Re D; Scheidhauer K; Ansén S; Dietlein M; Bischoff S; Bohlen H; Wolf J; Schicha H; Diehl V; Tesch H
Blood; 2001 Nov; 98(10):2930-4. PubMed ID: 11698273
[TBL] [Abstract][Full Text] [Related]
13. [First case in Spain of bacteremia by Methylobacterium thiocyanatum from Hickmann catheter in an immunosuppressed patient with Hodgkin's lymphoma].
García-Lozano T; Lorente Alegre P; Juan Bañón JL; Aznar Oroval E
Med Clin (Barc); 2012 Dec; 139(13):602-3. PubMed ID: 22613825
[No Abstract] [Full Text] [Related]
14. Chemotherapy: Advanced Hodgkin lymphoma--balancing toxicity and cure.
Lim SH; Johnson PW
Nat Rev Clin Oncol; 2011 Sep; 8(11):634-6. PubMed ID: 21894205
[No Abstract] [Full Text] [Related]
15. Communication challenges in a young man with Hodgkin's disease.
Medoff E
Cancer Pract; 2001; 9(6):272-6. PubMed ID: 11879328
[No Abstract] [Full Text] [Related]
16. Chemotherapy: Hodgkin lymphoma--absence of evidence not evidence of absence!
Borchmann P; Engert A; Diehl V
Nat Rev Clin Oncol; 2011 Oct; 8(11):636-7. PubMed ID: 21971592
[No Abstract] [Full Text] [Related]
17. Gemcitabine is active in relapsed Hodgkin's disease.
Lucas JB; Horwitz SM; Horning SJ; Sayegh A
J Clin Oncol; 1999 Aug; 17(8):2627-8. PubMed ID: 10561333
[No Abstract] [Full Text] [Related]
18. [Fatal Bacillus cereus sepsis and rhabdomyolysis in a patient with Hodgkin's disease].
Gómez-Herruz P; Gil-Fernández JJ; Guillen H; Arizcorreta A
Enferm Infecc Microbiol Clin; 2011 Mar; 29(3):232-3. PubMed ID: 21324561
[No Abstract] [Full Text] [Related]
19. High-dose BEAM chemotherapy with autologous haemopoietic stem cell transplantation for Hodgkin's disease is unlikely to be associated with a major increased risk of secondary MDS/AML.
Harrison CN; Gregory W; Hudson GV; Devereux S; Goldstone AH; Hancock B; Winfield D; MacMillan AK; Hoskin P; Newland AC; Milligan D; Linch DC
Br J Cancer; 1999 Oct; 81(3):476-83. PubMed ID: 10507773
[TBL] [Abstract][Full Text] [Related]
20. Impressive response to pegylated liposomal doxorubicin after allogeneic transplantation in a multi-relapsed Hodgkin's lymphoma.
Pellegrini C; Maglie R; Argnani L; Pileri S; Zinzani PL
Hematol Oncol; 2016 Mar; 34(1):49-51. PubMed ID: 25243375
[No Abstract] [Full Text] [Related]
[Next] [New Search]
